Digital Multi-Vital Sign Monitoring for Early Detection of Cytokine Release Syndrome from Bispecific T-Cell Engagers and Chimeric Antigen Receptor Therapy
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Blue Spark Technologies, Inc.
Start Date
April 26, 2024
End Date
May 31, 2029
Administered By
Duke Cancer Institute
Awarded By
Blue Spark Technologies, Inc.
Start Date
April 26, 2024
End Date
May 31, 2029